Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Interactions“
Suchtreffer
Begriffe & Kennungen
Alprolix · 4.5 · No interactions of ALPROLIX with other medicinal products have been reported. No interaction studies have been
Eintrag öffnenAltuvoct · 4.5 · No interactions of human coagulation factor VIII (rDNA) products with other medicinal products have been repor
Eintrag öffnenAmlodipine / Valsartan Mylan · 4.5 · Interactions common to the combination
Eintrag öffnenAmlodipine / Valsartan Mylan · 4.5 · Interactions linked to amlodipine
Eintrag öffnenAmlodipine / Valsartan Mylan · 4.5 · Interactions linked to valsartan
Eintrag öffnenAmlodipine / Valsartan Mylan · 4.5 · Others In monotherapy with valsartan, no interactions of clinical significance have been found with the follow
Eintrag öffnenAmplification of social interactions
Eintrag öffnenAnoro Ellipta (previously Anoro) · 4.5 · Clinically significant interactions mediated by umeclidinium/vilanterol at clinical doses are considered unlik
Eintrag öffnenAnoro Ellipta (previously Anoro) · 4.5 · Metabolic and transporter based interactions
Eintrag öffnenApidra · 4.5 · Studies on pharmacokinetic interactions have not been performed. Based on empirical knowledge from similar med
Eintrag öffnenApixaban Accord · 4.5 · Other concomitant therapies No clinically significant pharmacokinetic or pharmacodynamic interactions were obs
Eintrag öffnenApixaban Accord · 4.5 · Other concomitant therapies No clinically significant pharmacokinetic or pharmacodynamic interactions were obs
Eintrag öffnenApixaban Accord · 4.5 · Pharmacokinetic or pharmacodynamic interactions were not evident when apixaban was coadministered with ASA 325
Eintrag öffnenApixaban Accord · 4.5 · Pharmacokinetic or pharmacodynamic interactions were not evident when apixaban was coadministered with ASA 325
Eintrag öffnenAprovel · 4.5 · 18 extent by glucuronidation. No significant pharmacokinetic or pharmacodynamic interactions were observed whe
Eintrag öffnenAprovel · 4.5 · 31 extent by glucuronidation. No significant pharmacokinetic or pharmacodynamic interactions were observed whe
Eintrag öffnenAprovel · 4.5 · 5 extent by glucuronidation. No significant pharmacokinetic or pharmacodynamic interactions were observed when
Eintrag öffnenAprovel · 4.5 · 57 Additional information on irbesartan interactions: in clinical studies, the pharmacokinetic of irbesartan i
Eintrag öffnenAprovel · 4.5 · Additional information on irbesartan interactions: in clinical studies, the pharmacokinetic of irbesartan is n
Eintrag öffnenAprovel · 4.5 · Additional information on irbesartan interactions: in clinical studies, the pharmacokinetic of irbesartan is n
Eintrag öffnen